BioSpace News Archive

Arvinas, Inc. announced that management will participate in a fireside chat at the Bank of America Securities 2022 Healthcare Conference on Tuesday, May 10 at 7:00 p.m. ET /4:00 p.m. PT in Las Vegas.

Spero Therapeutics, Inc. (Nasdaq: SPRO), today announced that it will immediately defer current commercialization activities for tebipenem HBr based on feedback from a recent Late Cycle Meeting (LCM) with the U.S. Food and Drug Administration (FDA) regarding Spero’s New Drug Application (NDA) for tebipenem HBr.

Oncotelic Therapeutics, Inc., announced the appointment of Dr. Fatih Uckun as its Chief Medical Officer.

Heat Biologics, Inc. today announced that it has completed its name change from Heat Biologics, Inc. to NightHawk Biosciences, Inc.

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today reported business highlights and financial results for the first quarter ended March 31, 2022.

Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces that it has strengthened its second-quarter production expansion with a new vendor quality assurance program.

BioXcel Therapeutics, Inc. today announced the first patient has been dosed in the Phase 3 TRANQUILITY II study of BXCL501.

Taysha Gene Therapies, Inc. today announced that it has been granted orphan drug designation from the European Commission for TSHA-120, an intrathecally dosed AAV9 gene therapy currently in ongoing clinical evaluation for the treatment of giant axonal neuropathy (GAN).

Apellis Pharmaceuticals, Inc. announced today that renowned hematologist Peter Hillmen, MB ChB, PhD, will join the company as head of hematology engagement, effective May 23, 2022.

rBIO, an early-stage synthetic biology company focused on reducing the cost of increasingly costly biologic therapies, announced refinement of its bacteria-based production of insulin.